MBG logo
Focused certification exam prep
Start practice

What Is MBG?

TL;DR
  • MBG here means Medical Biochemical Genetics, examined under the American Board of Medical Genetics and Genomics (ABMGG).
  • The 2025 blueprint lists 15 content domains; amino acids carry the most weight at 15%.
  • Amino acids, lipids, organic acids, and lysosomes together make up roughly half of the blueprint.
  • The Laboratory domain is 8%, so interpreting analytes and methods is a real scoring area.

What MBG Means Here

On this site, MBG stands for Medical Biochemical Genetics. It refers to the subspecialty examination in biochemical genetics offered through the American Board of Medical Genetics and Genomics (ABMGG). It is the discipline that diagnoses and manages inborn errors of metabolism: conditions in which a defective enzyme, transporter, or cofactor pathway disrupts the body's chemistry.

The acronym is used by other, unrelated credentials in other fields. Nothing in this article applies to those; everything below concerns the biochemical genetics specialty and the content the ABMGG publishes for it. If you are still sorting out terminology, our short explainers on what MBG stands for and MBG meaning cover the naming question directly.

Who Governs the Credential

The ABMGG is the certifying body. It publishes a Biochemical Genetics Blueprint and Content Codes document, and the 2025 edition is the source for the exam structure described in this article. That document lists the official content topics and their approximate percentages. It is the closest thing the specialty has to a public syllabus, and it should anchor your preparation.

For a deeper look at eligibility and prerequisites, see our guide to MBG requirements. For a broader overview of the credential itself, the MBG certification page is a good companion to this one.

What Biochemical Genetics Actually Covers

Biochemical genetics sits where clinical medicine, enzymology, and the clinical laboratory meet. A practitioner is expected to move comfortably in three directions at once:

  • From phenotype to pathway. A child with vomiting, lethargy, and hyperammonemia raises a short list of urea cycle and organic acid disorders. The reasoning runs from clinical picture to the metabolic block.
  • From analyte to diagnosis. An acylcarnitine profile, a urine organic acid pattern, or a plasma amino acid result has to be translated into a specific enzyme deficiency.
  • From diagnosis to management. Dietary restriction, cofactor supplementation, enzyme replacement, and emergency protocols all follow from knowing exactly where the pathway is broken.

The exam blueprint mirrors this. It is organized not by clinical presentation but by biochemical category, which tells you how to study: learn each pathway as a chain of substrates, enzymes, cofactors, and products, and know what accumulates or goes missing when a step fails.

How the Blueprint Divides the Exam

The 2025 blueprint names 15 domains with approximate weights. Here they are in the order the blueprint lists them:

DomainApproximate Weight
Amino acids15%
Organic acids12%
Cofactors7%
Carbohydrates10%
Lipids13%
Lysosomes12%
Mitochondria7%
Peroxisomes3%
Purines and pyrimidines3%
Transport3%
Creatine1%
Neurotransmitters2%
Metals3%
Laboratory8%
Other disease category3%

Notice the shape of that distribution. Five domains (amino acids, lipids, organic acids, lysosomes, and carbohydrates) account for 62% of the blueprint between them. The remaining ten share the other 38%. A full walkthrough of each area is in our complete guide to all 15 MBG content areas.

Read the weights as approximate: The blueprint gives approximate percentages, not guaranteed question counts per domain. Use them to allocate study time, not to predict exactly how many items you will see from any single area.

High-Yield Content Inside the Big Domains

Because the largest domains carry so much of the blueprint, depth there pays off. Below is the kind of material a candidate should be able to reason through, framed around mechanisms rather than memorized lists.

Amino Acids (15%)

The single largest domain. Candidates must understand how disorders of amino acid catabolism, synthesis, and the urea cycle present biochemically and clinically.

  • Phenylalanine, tyrosine, branched-chain, sulfur-containing, and urea cycle pathways
  • Which amino acids rise or fall in each disorder, and in which specimen
  • Dietary and pharmacologic principles of management

Lipids (13%)

This domain spans fatty acid oxidation and broader lipid metabolism. Pattern recognition from acylcarnitine profiles is central.

  • Chain-length-specific fatty acid oxidation defects and their characteristic profiles
  • Carnitine cycle disorders
  • Ketone body and cholesterol or sterol synthesis considerations

Organic Acids (12%)

Organic acidemias are classic presentations of metabolic decompensation. Know the enzyme step, the accumulating metabolites, and the acute management logic.

  • Propionate and methylmalonate pathways, including their link to cobalamin metabolism
  • Urine organic acid patterns and the metabolites that define each disorder
  • Acute metabolic crisis recognition and response

Lysosomes (12%)

Lysosomal storage disorders are examined through their enzymes, stored substrates, and treatment landscape.

  • Mucopolysaccharidoses, sphingolipidoses, glycoproteinoses, and related categories
  • Enzyme assays and urine glycosaminoglycan or oligosaccharide testing
  • Enzyme replacement and other disease-directed therapies

Carbohydrates (10%)

Disorders of glycogen, galactose, fructose, and gluconeogenesis often present with hypoglycemia, hepatic involvement, or muscle symptoms.

  • Glycogen storage disease types and their distinguishing features
  • Galactosemia and hereditary fructose intolerance
  • Fasting tolerance and the dietary logic for each disorder

If you want help converting this into a plan, the MBG study guide walks through structuring your preparation around these weights.

Small Domains That Still Matter

It is tempting to skip the low-percentage domains. That is usually a mistake, because several of them are conceptually compact and easy to learn well, which makes them efficient points.

  • Cofactors (7%) and Mitochondria (7%) overlap heavily with the big domains. Vitamin-responsive disorders and oxidative phosphorylation concepts reappear in organic acid and lipid questions.
  • Peroxisomes (3%) covers very-long-chain fatty acid and plasmalogen concepts, a small but well-defined body of knowledge.
  • Purines and pyrimidines (3%), Transport (3%), and Metals (3%) each reward a focused review of a limited set of well-characterized disorders.
  • Neurotransmitters (2%) and Creatine (1%) are the smallest areas, but the creatine synthesis and transport disorders and the neurotransmitter pathway defects are tightly bounded topics.
  • Other disease category (3%) is a catch-all, a reminder that the blueprint does not claim to sort every metabolic condition neatly.
Why the small domains compound: Together, Cofactors, Mitochondria, Peroxisomes, Purines and pyrimidines, Transport, Creatine, Neurotransmitters, Metals, and Other disease category add up to 29% of the blueprint. Ignoring them wholesale gives away a meaningful share of the exam.

The Laboratory Domain

At 8%, Laboratory is larger than any of the small domains and larger than Cofactors or Mitochondria on their own. It is also the domain that distinguishes this specialty from purely clinical genetics: a biochemical geneticist is expected to understand how results are produced and what can go wrong.

Expect to reason about topics such as:

  • Which specimen type suits which question (plasma, urine, dried blood spot, cerebrospinal fluid, cultured cells)
  • Strengths and limits of the major analytical approaches used for amino acids, organic acids, acylcarnitines, and enzyme assays
  • Newborn screening concepts, including how a screening result differs from a confirmed diagnosis
  • Pre-analytic variables such as fasting state, sample handling, and medications that can distort a profile

Key Takeaway

Treat Laboratory as a bridge domain. The same knowledge of specimens, methods, and interferences that earns points here also helps you interpret profiles in the amino acid, organic acid, and lipid domains.

What Public Sources Do Not Confirm

Candidates often ask for exam mechanics that the public record simply does not establish. The sources reviewed for this article did not verify a public question count, fee, pass rate, or testing provider for this specialty examination. Rather than guess, we recommend confirming those details directly with the ABMGG, which is the authoritative source.

That caution applies to related questions too. Our pages on MBG certification cost, MBG pass rate, MBG passing score, and MBG exam dates are the places to look for how we handle each of those, and what is and is not verifiable. If a number is quoted to you without a source, treat it skeptically.

A practical rule: Build your preparation around the published blueprint and verify logistics with the ABMGG. Content you can control; unverified statistics you cannot.

Who Works in This Field

Biochemical genetics is a small, specialized discipline, and its practitioners cluster in academic and clinical settings that diagnose and follow patients with inborn errors of metabolism. Typical environments include:

  • Academic medical centers and children's hospitals with metabolic or genetics clinics
  • Clinical biochemical genetics laboratories that run and interpret specialized metabolic testing
  • Newborn screening programs and the confirmatory testing pathways attached to them
  • Research and translational programs developing new diagnostics and therapies for metabolic disease

We deliberately do not quote earnings figures here, because the sources reviewed for this article do not support specific numbers. For a discussion of the career side, see MBG jobs, the MBG salary guide, and our analysis of whether the certification is worth it.

Sequencing Your Preparation Around the Blueprint

Rather than a generic schedule, tie your calendar to how the blueprint is built. One workable order treats the domains as layers:

Phase 1

Core pathways first

  • Amino acids (15%) and organic acids (12%) together, since propionate, methylmalonate, and branched-chain pathways intersect
  • Draw each pathway from memory, marking enzyme, cofactor, and accumulating metabolite
Phase 2

Energy and storage

  • Lipids (13%), carbohydrates (10%), and mitochondria (7%) as one connected energy-metabolism block
  • Practice reading acylcarnitine and glucose-related patterns
Phase 3

Storage and structure

  • Lysosomes (12%) and peroxisomes (3%), organized by organelle and stored substrate
Phase 4

Specialty and laboratory sweep

  • Cofactors, purines and pyrimidines, transport, metals, creatine, neurotransmitters, and other disease category
  • Laboratory (8%) review, then full mixed-domain practice

The logic is that early phases build the vocabulary the later phases reuse. Cofactor and mitochondrial concepts, for instance, make far more sense once you have seen the organic acid and lipid disorders they explain. For quick last-pass review, the MBG cheat sheet condenses must-know facts, and our guide on how hard the MBG exam is helps you calibrate effort. To pressure-test what you have learned, work through realistic items on the MBG practice test site.

Frequently Asked Questions

What does MBG mean in this context?

It means Medical Biochemical Genetics, the specialty concerned with diagnosing and managing inborn errors of metabolism. The examination is governed by the American Board of Medical Genetics and Genomics (ABMGG). Other credentials use the same letters, but they are unrelated.

Which domain is the largest on the exam blueprint?

Amino acids, at approximately 15% per the ABMGG 2025 blueprint. Lipids (13%), organic acids (12%), and lysosomes (12%) follow. Weights are approximate, so use them for planning rather than as exact question counts.

How many questions are on the exam, and what does it cost?

Public sources reviewed did not verify a question count, fee, pass rate, or testing provider for this specialty examination. Confirm these details directly with the ABMGG rather than relying on unsourced figures.

Is the Laboratory domain worth studying seriously?

Yes. At 8%, it outweighs several clinical domains, and its content on specimens, methods, and interferences also sharpens your interpretation of profiles in amino acid, organic acid, and lipid questions.

Can I skip the very small domains like Creatine and Neurotransmitters?

It is risky. Creatine is about 1% and Neurotransmitters about 2%, but together with the other small domains they represent a meaningful portion of the blueprint. Their topics are bounded and learnable, so brief, focused review is usually an efficient investment. For more depth, see our domain-by-domain guide.

Understanding what MBG is comes down to knowing that it is a pathway-centered specialty examined through a published blueprint. Start with that document, weight your time toward the largest domains without abandoning the small ones, and verify logistics with the ABMGG. When you are ready to test yourself, head to the MBG Exam Prep practice tests.

Ready to pass your MBG exam?

Put this into practice with free MBG questions across every exam domain.